Thyrocare to acquire diagnostic and pathological services of Vimta Lab
Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and pathological services business of Vimta Labs.
Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025.

Best Stocks To Buy Today
3 mins read . Aug 7, 2025

Muhurat Trading 2025: Meaning, Date, Time, Tips & Best Stock Picks
8 mins read . Aug 7, 2025

Low Price Shares
0 mins read . Dec 18, 2024

Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •